Side-by-side comparison of AI visibility scores, market position, and capabilities
Mars/Kellanova-owned apple-cinnamon breakfast cereal with orange and green ring mascots; Kellanova acquired by Mars for $36B in 2025 competing with Froot Loops for children's cereal.
Apple Jacks is a Kellogg's breakfast cereal brand producing apple and cinnamon-flavored cereal rings that have been a popular choice since 1965 — targeting children and families with the distinctive orange and green ring-shaped pieces, recognizable mascots CinnaMon (orange character) and Bad Apple (green character), and the memorable "Why do kids love Apple Jacks? We just do." tagline. Apple Jacks is owned by Kellanova (formerly Kellogg's North America cereal business, now acquired by Mars Inc. in 2024 for $36 billion).\n\nApple Jacks' cereal is a sweetened corn and oat puff with apple and cinnamon flavoring, fortified with vitamins and minerals (vitamin C, iron, B vitamins) that parents consider when evaluating breakfast cereal choices for their children. The cereal's mild sweetness and distinctive shape have maintained its popularity across generations — adults who grew up eating Apple Jacks as children often purchase it for their own children, creating multi-generational brand loyalty. The cereal is sold in standard and large/family-size boxes across US grocery chains.\n\nIn 2025, Apple Jacks sits within Mars Inc.'s breakfast cereal portfolio following the $36 billion acquisition of Kellanova (which included Frosted Flakes, Froot Loops, Corn Flakes, Rice Krispies, and other Kellogg's brands alongside Apple Jacks, Cheez-It, and Pringles). Mars completed the Kellanova acquisition in March 2025, creating one of the largest food companies in the world. Apple Jacks competes with Froot Loops (now a fellow Mars/Kellanova brand), Trix (General Mills), and Lucky Charms for the children's sweetened cereal market. The 2025 strategy focuses on maintaining Apple Jacks' shelf presence in the competitive breakfast cereal aisle and leveraging Mars's marketing capabilities to reinvigorate the brand's connection with current child consumers.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.